tradingkey.logo

CeriBell Inc

CBLL
查看詳細走勢圖
21.420USD
+0.130+0.61%
收盤 12/24, 13:00美東報價延遲15分鐘
793.58M總市值
虧損本益比TTM

CeriBell Inc

21.420
+0.130+0.61%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.61%

5天

-2.59%

1月

+40.37%

6月

+15.85%

今年開始到現在

-17.23%

1年

-19.84%

查看詳細走勢圖

TradingKey CeriBell Inc股票評分

單位: USD 更新時間: 2025-12-23

操作建議

CeriBell Inc當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名39/208位。機構持股佔比非常高,近一個月多位分析師給出公司評級為強力買入。最高目標價26.00。中期看,股價處於上升通道。近一個月,市場表現很強,技術面和基本面綜合得分較高,很強的走勢得到基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

CeriBell Inc評分

相關信息

行業排名
39 / 208
全市場排名
113 / 4568
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 8 分析師
強力買入
評級
26.000
目標均價
+28.59%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

CeriBell Inc亮點

亮點風險
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
業績高增長
公司營業收入穩步增長,連續3年增長152.47%
業績增長期
公司處於發展階段,最新年度總收入65.44M美元
估值合理
公司最新PE估值-15.13,處於3年歷史合理位
機構減倉
最新機構持股30.92M股,環比減少0.09%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉2.34K股

CeriBell Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

CeriBell Inc簡介

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
公司代碼CBLL
公司CeriBell Inc
CEOChao (Xingjuan)
網址https://ceribell.com/

常見問題

CeriBell Inc(CBLL)的當前股價是多少?

CeriBell Inc(CBLL)的當前股價是 21.420。

CeriBell Inc 的股票代碼是什麼?

CeriBell Inc的股票代碼是CBLL。

CeriBell Inc股票的52週最高點是多少?

CeriBell Inc股票的52週最高點是27.215。

CeriBell Inc股票的52週最低點是多少?

CeriBell Inc股票的52週最低點是10.010。

CeriBell Inc的市值是多少?

CeriBell Inc的市值是793.58M。

CeriBell Inc的淨利潤是多少?

CeriBell Inc的淨利潤為-40.45M。

現在CeriBell Inc(CBLL)的股票是買入、持有還是賣出?

根據分析師評級,CeriBell Inc(CBLL)的總體評級為--,目標價格為26.000。

CeriBell Inc(CBLL)股票的每股收益(EPS TTM)是多少

CeriBell Inc(CBLL)股票的每股收益(EPS TTM)是-1.407。
KeyAI